• 1
    Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910922.
  • 2
    Kagnoff MF. Celiac disease: Pathogenesis of a model immunogenetic disease. J Clin Invest 2007; 117: 4149.
  • 3
    United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam. Eur J Gastroenterol Hepatol 2001; 13: 11231128.
  • 4
    Cellier C, Patey N, Mauvieux L, Jabri B, Delabesse E, Cervoni JP, Burtin ML, Guy-Grand D, Bouhnik Y, Modigliani R, Barbier JP, Macintyre E, Brousse N, Cerf-Bensussan N. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471481.
  • 5
    Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ. Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: Retrospective evaluation of single centre experience. Gut 2007; 57: 13731378.
  • 6
    Isaacson PG, Wright DH, Ralfkiaer E. Enteropathy-type T-cell lymphoma. In: JaffeES, HarrisNL, SteinH, VardimanJW, World Health Organization, editors. Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC press; 2001. pp 208209.
  • 7
    Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999; 94: 260264.
  • 8
    Cellier C, Delabesse E, Helmer C, Patey N, Matushansky C, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000; 356: 203208.
  • 9
    Carbonnel F, Grollet-Bioul L, Brouet JC, Teilhac MF, Cosnes J, Angonin R, Deschaseaux M, Châtelet FP, Gendre JP, Sigaux F. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998; 92: 38793886.
  • 10
    Daum S, Hummel M, Weiss D, Peters M, Wiedenmann B, Shaper F, Stein H, Riecken EO, Foss H. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma. Digestion 2000; 62: 6065.
  • 11
    Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clin Immunol 2008; 126: 4856.
  • 12
    Sanchez-Munoz LB, Santon A, Cano A, Lopez A, Almeida J, Orfao A, Escribano L, Roy G. Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue. Eur J Gastroenterol Hepatol 2008; 20: 478487.
  • 13
    Verkarre V, Asnafi V, Lecomte T, Patery Mariaud-de-Serre N, Leborgne M, Grosdidier E, Le Bihan C, Macintyre E, Cellier C, Cerf-Bensussan N, Brousse N. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003; 52: 205211.
  • 14
    Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: Definition, diagnosis and treatment. Scand J Gastroenterol Suppl 2004; 241: 7884.
  • 15
    Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19: 413424.
  • 16
    Vahedi K, Mascart F, Mary JY, Laberenne JE, Bounhnik Y, Morin MC, Ocmant A, Velly C, Colombel JF, Matuchansky C. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003; 98: 10791087.
    Direct Link:
  • 17
    Mallant M, Hadithi M, Al-Toma AB, Kater M, Jacobs M, Manoliu R, Mulder C, van Waesberghe JH. Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J Gastroenterol 2007; 13: 16961700.
  • 18
    Hadithi M, Mallant M, Oudejans J, van Waesberghe JH, Mulder CJ, Comans EF. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 2006; 47: 16221627.
  • 19
    Hadithi M, Al-Toma A, Oudejans J, van Bodegraven AA, Mulder CJ, Jacobs M. The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol 2007; 102: 987996.
    Direct Link:
  • 20
    Al-Toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE, Ossenkoppele GJ, Huijgens PC, Mulder CJ. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007; 109: 22432249.
  • 21
    Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006; 4: 13221327.
  • 22
    Goerres MS, Meijer JW, Wahab PJ, Kerckhaerrt JA, Groenen PJ, Van Krieken JH, Mulder CJ. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18: 487494.
  • 23
    Wahab PJ, Meijer JW, Goerres MS, Mulder CJ. Coeliac disease: Changing views on gluten-sensitive enteropathy. Scand J Gastroenterol Suppl 2002; 236: 6065.
  • 24
    Madrigal L, Lynch S, Feighery C, Weir D, Kelleher D, O'Farrelly C. Flow cytometric analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies. J Immunol Methods 1993; 158: 207214.
  • 25
    Di Sabatino SA, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM, Paulli M, Cifone MG, Corazza GR. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006; 55: 469477.
  • 26
    Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330354.
  • 27
    Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: Slow and incomplete recovery. Am J Clin Pathol 2002; 118: 459463.
  • 28
    Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888894.
    Direct Link:
  • 29
    Bruggemann M, White H, Gaulard P, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 2007; 21: 215221.
  • 30
    Verbeek WH, von Blomberg BM, Scholten PE, Kuik DJ, Mulder CJ, Schreurs MW. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol 2008; 103: 31523158.
    Direct Link:
  • 31
    Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21: 357366.
  • 32
    Goerres MS, Mulder CJ, Wahab PJ, Kerckhaert JA, Dijk VH. Peripheral blood phenotyping in (refractory) coeliac disease as a marker of pre-malignancy? [abstract]. Gut 2003; 52( Suppl VI): A20.